A naïve pooled data approach for extrapolation of Phase 0 microdose trials to therapeutic dosing regimens
Abstract Microdosing is a strategy to obtain knowledge of human pharmacokinetics prior to Phase I clinical trials. The most frequently used method to extrapolate microdose (≤100 μg) pharmacokinetics to therapeutic doses is based on linear extrapolation from a noncompartmental analysis (NCA) with a t...
Saved in:
Main Authors: | Lisa van derHeijden (Author), Merel vanNuland (Author), Jos Beijnen (Author), Alwin Huitema (Author), Thomas Dorlo (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of microtracers in food‐effect trials: An alternative study design for toxic drugs with long half‐lives exemplified by the case for alectinib
by: L. T. van derHeijden, et al.
Published: (2023) -
Editorial: Incorporating Phase 0 microdosing as a powerful tool into a new vision of drug development
by: H. Markus Weiss, et al.
Published: (2024) -
A Review of CYP3A Drug-Drug Interaction Studies: Practical Guidelines for Patients Using Targeted Oral Anticancer Drugs
by: Laura Molenaar-Kuijsten, et al.
Published: (2021) -
Predictability of human exposure by human‐CYP3A4‐transgenic mouse models: A meta‐analysis
by: David Damoiseaux, et al.
Published: (2024) -
Physiologically‐based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milk
by: David Damoiseaux, et al.
Published: (2023)